nodes	percent_of_prediction	percent_of_DWPC	metapath
Torasemide—CYP2C9—brain cancer	0.867	1	CbGaD
Torasemide—PTGS1—Etoposide—brain cancer	0.0149	0.634	CbGbCtD
Torasemide—CYP2C8—Etoposide—brain cancer	0.00861	0.366	CbGbCtD
Torasemide—Throat sore—Lomustine—brain cancer	0.00468	0.051	CcSEcCtD
Torasemide—Oropharyngeal discomfort—Lomustine—brain cancer	0.00464	0.0506	CcSEcCtD
Torasemide—Oropharyngeal pain—Lomustine—brain cancer	0.00371	0.0405	CcSEcCtD
Torasemide—Hyperuricaemia—Hydroxyurea—brain cancer	0.00179	0.0195	CcSEcCtD
Torasemide—Haemoglobin—Lomustine—brain cancer	0.0017	0.0186	CcSEcCtD
Torasemide—Haemorrhage—Lomustine—brain cancer	0.0017	0.0185	CcSEcCtD
Torasemide—Blood uric acid increased—Hydroxyurea—brain cancer	0.00169	0.0184	CcSEcCtD
Torasemide—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00149	0.0838	CbGpPWpGaD
Torasemide—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.0014	0.0153	CcSEcCtD
Torasemide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00134	0.0753	CbGpPWpGaD
Torasemide—Leukopenia—Lomustine—brain cancer	0.00132	0.0144	CcSEcCtD
Torasemide—Pancreatitis—Procarbazine—brain cancer	0.00132	0.0144	CcSEcCtD
Torasemide—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00125	0.0705	CbGpPWpGaD
Torasemide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00122	0.0685	CbGpPWpGaD
Torasemide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00119	0.0672	CbGpPWpGaD
Torasemide—Thrombocytopenia—Lomustine—brain cancer	0.00118	0.0129	CcSEcCtD
Torasemide—Pain—Carboplatin—brain cancer	0.00118	0.0128	CcSEcCtD
Torasemide—Hyperuricaemia—Etoposide—brain cancer	0.00112	0.0122	CcSEcCtD
Torasemide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00109	0.0612	CbGpPWpGaD
Torasemide—Haemoglobin—Procarbazine—brain cancer	0.00108	0.0118	CcSEcCtD
Torasemide—Haemorrhage—Procarbazine—brain cancer	0.00108	0.0117	CcSEcCtD
Torasemide—Blood uric acid increased—Etoposide—brain cancer	0.00106	0.0115	CcSEcCtD
Torasemide—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00104	0.0584	CbGpPWpGaD
Torasemide—Pancreatitis—Hydroxyurea—brain cancer	0.00102	0.0111	CcSEcCtD
Torasemide—Thirst—Temozolomide—brain cancer	0.000988	0.0108	CcSEcCtD
Torasemide—Hyponatraemia—Carmustine—brain cancer	0.000977	0.0107	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000973	0.0106	CcSEcCtD
Torasemide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000925	0.0521	CbGpPWpGaD
Torasemide—Tension—Procarbazine—brain cancer	0.000919	0.01	CcSEcCtD
Torasemide—Nervousness—Procarbazine—brain cancer	0.00091	0.00992	CcSEcCtD
Torasemide—Hypokalaemia—Carmustine—brain cancer	0.000886	0.00965	CcSEcCtD
Torasemide—Dehydration—Temozolomide—brain cancer	0.000875	0.00953	CcSEcCtD
Torasemide—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000868	0.0489	CbGpPWpGaD
Torasemide—Hypokalaemia—Temozolomide—brain cancer	0.000856	0.00933	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000847	0.00923	CcSEcCtD
Torasemide—Syncope—Procarbazine—brain cancer	0.00084	0.00916	CcSEcCtD
Torasemide—Leukopenia—Procarbazine—brain cancer	0.000839	0.00914	CcSEcCtD
Torasemide—Haemoglobin—Hydroxyurea—brain cancer	0.000837	0.00912	CcSEcCtD
Torasemide—Haemorrhage—Hydroxyurea—brain cancer	0.000833	0.00908	CcSEcCtD
Torasemide—Loss of consciousness—Procarbazine—brain cancer	0.000823	0.00898	CcSEcCtD
Torasemide—Cough—Procarbazine—brain cancer	0.000818	0.00891	CcSEcCtD
Torasemide—Myalgia—Procarbazine—brain cancer	0.000798	0.00869	CcSEcCtD
Torasemide—Arthralgia—Procarbazine—brain cancer	0.000798	0.00869	CcSEcCtD
Torasemide—Vomiting—Lomustine—brain cancer	0.000766	0.00835	CcSEcCtD
Torasemide—Oedema—Procarbazine—brain cancer	0.000765	0.00833	CcSEcCtD
Torasemide—Hyperglycaemia—Carmustine—brain cancer	0.000759	0.00827	CcSEcCtD
Torasemide—Shock—Procarbazine—brain cancer	0.000752	0.0082	CcSEcCtD
Torasemide—Erectile dysfunction—Temozolomide—brain cancer	0.000749	0.00816	CcSEcCtD
Torasemide—Thrombocytopenia—Procarbazine—brain cancer	0.000749	0.00816	CcSEcCtD
Torasemide—Hyperglycaemia—Temozolomide—brain cancer	0.000733	0.00799	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000719	0.00783	CcSEcCtD
Torasemide—Nausea—Lomustine—brain cancer	0.000715	0.0078	CcSEcCtD
Torasemide—Hypotension—Procarbazine—brain cancer	0.000714	0.00779	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000697	0.00759	CcSEcCtD
Torasemide—Insomnia—Procarbazine—brain cancer	0.000692	0.00754	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000678	0.00739	CcSEcCtD
Torasemide—Haemoglobin—Carmustine—brain cancer	0.000677	0.00738	CcSEcCtD
Torasemide—Haemorrhage—Carmustine—brain cancer	0.000673	0.00734	CcSEcCtD
Torasemide—Haemoglobin—Temozolomide—brain cancer	0.000654	0.00713	CcSEcCtD
Torasemide—Pain—Procarbazine—brain cancer	0.000654	0.00713	CcSEcCtD
Torasemide—Constipation—Procarbazine—brain cancer	0.000654	0.00713	CcSEcCtD
Torasemide—Haemorrhage—Temozolomide—brain cancer	0.000651	0.00709	CcSEcCtD
Torasemide—Leukopenia—Hydroxyurea—brain cancer	0.000649	0.00707	CcSEcCtD
Torasemide—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000643	0.0362	CbGpPWpGaD
Torasemide—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000618	0.0348	CbGpPWpGaD
Torasemide—Erythema multiforme—Temozolomide—brain cancer	0.000615	0.00671	CcSEcCtD
Torasemide—Oedema—Hydroxyurea—brain cancer	0.000592	0.00645	CcSEcCtD
Torasemide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000579	0.00632	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000575	0.00627	CcSEcCtD
Torasemide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000574	0.0323	CbGpPWpGaD
Torasemide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000552	0.0311	CbGpPWpGaD
Torasemide—Asthenia—Procarbazine—brain cancer	0.000549	0.00598	CcSEcCtD
Torasemide—Leukopenia—Carmustine—brain cancer	0.000525	0.00572	CcSEcCtD
Torasemide—Diarrhoea—Procarbazine—brain cancer	0.000523	0.0057	CcSEcCtD
Torasemide—Dyspepsia—Hydroxyurea—brain cancer	0.000521	0.00568	CcSEcCtD
Torasemide—Angioedema—Temozolomide—brain cancer	0.000518	0.00564	CcSEcCtD
Torasemide—Leukopenia—Temozolomide—brain cancer	0.000507	0.00553	CcSEcCtD
Torasemide—Constipation—Hydroxyurea—brain cancer	0.000506	0.00552	CcSEcCtD
Torasemide—Pain—Hydroxyurea—brain cancer	0.000506	0.00552	CcSEcCtD
Torasemide—Dizziness—Procarbazine—brain cancer	0.000506	0.00551	CcSEcCtD
Torasemide—Myalgia—Carmustine—brain cancer	0.000499	0.00544	CcSEcCtD
Torasemide—Chest pain—Carmustine—brain cancer	0.000499	0.00544	CcSEcCtD
Torasemide—Cough—Temozolomide—brain cancer	0.000494	0.00539	CcSEcCtD
Torasemide—Erythema multiforme—Etoposide—brain cancer	0.000492	0.00537	CcSEcCtD
Torasemide—Vomiting—Procarbazine—brain cancer	0.000486	0.0053	CcSEcCtD
Torasemide—Myalgia—Temozolomide—brain cancer	0.000482	0.00526	CcSEcCtD
Torasemide—Arthralgia—Temozolomide—brain cancer	0.000482	0.00526	CcSEcCtD
Torasemide—Rash—Procarbazine—brain cancer	0.000482	0.00525	CcSEcCtD
Torasemide—Dermatitis—Procarbazine—brain cancer	0.000482	0.00525	CcSEcCtD
Torasemide—Headache—Procarbazine—brain cancer	0.000479	0.00522	CcSEcCtD
Torasemide—Oedema—Carmustine—brain cancer	0.000478	0.00521	CcSEcCtD
Torasemide—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000478	0.0269	CbGpPWpGaD
Torasemide—Thrombocytopenia—Carmustine—brain cancer	0.000468	0.00511	CcSEcCtD
Torasemide—Oedema—Temozolomide—brain cancer	0.000462	0.00504	CcSEcCtD
Torasemide—Nausea—Procarbazine—brain cancer	0.000454	0.00495	CcSEcCtD
Torasemide—Thrombocytopenia—Temozolomide—brain cancer	0.000453	0.00493	CcSEcCtD
Torasemide—Hypotension—Carmustine—brain cancer	0.000447	0.00487	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000436	0.00475	CcSEcCtD
Torasemide—Insomnia—Carmustine—brain cancer	0.000433	0.00472	CcSEcCtD
Torasemide—Asthenia—Hydroxyurea—brain cancer	0.000425	0.00463	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000421	0.00459	CcSEcCtD
Torasemide—Insomnia—Temozolomide—brain cancer	0.000418	0.00456	CcSEcCtD
Torasemide—Pain—Carmustine—brain cancer	0.000409	0.00446	CcSEcCtD
Torasemide—Constipation—Carmustine—brain cancer	0.000409	0.00446	CcSEcCtD
Torasemide—Dyspepsia—Temozolomide—brain cancer	0.000407	0.00444	CcSEcCtD
Torasemide—Leukopenia—Etoposide—brain cancer	0.000406	0.00442	CcSEcCtD
Torasemide—Diarrhoea—Hydroxyurea—brain cancer	0.000405	0.00441	CcSEcCtD
Torasemide—Loss of consciousness—Etoposide—brain cancer	0.000398	0.00434	CcSEcCtD
Torasemide—Cough—Etoposide—brain cancer	0.000396	0.00431	CcSEcCtD
Torasemide—Pain—Temozolomide—brain cancer	0.000395	0.00431	CcSEcCtD
Torasemide—Constipation—Temozolomide—brain cancer	0.000395	0.00431	CcSEcCtD
Torasemide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000394	0.0222	CbGpPWpGaD
Torasemide—Dizziness—Hydroxyurea—brain cancer	0.000391	0.00427	CcSEcCtD
Torasemide—Chest pain—Etoposide—brain cancer	0.000386	0.00421	CcSEcCtD
Torasemide—Vomiting—Hydroxyurea—brain cancer	0.000376	0.0041	CcSEcCtD
Torasemide—Rash—Hydroxyurea—brain cancer	0.000373	0.00407	CcSEcCtD
Torasemide—Dermatitis—Hydroxyurea—brain cancer	0.000373	0.00406	CcSEcCtD
Torasemide—Headache—Hydroxyurea—brain cancer	0.000371	0.00404	CcSEcCtD
Torasemide—Thrombocytopenia—Etoposide—brain cancer	0.000362	0.00395	CcSEcCtD
Torasemide—Nausea—Hydroxyurea—brain cancer	0.000351	0.00383	CcSEcCtD
Torasemide—Hypotension—Etoposide—brain cancer	0.000346	0.00377	CcSEcCtD
Torasemide—Asthenia—Carmustine—brain cancer	0.000343	0.00374	CcSEcCtD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000335	0.0189	CbGpPWpGaD
Torasemide—Asthenia—Temozolomide—brain cancer	0.000332	0.00362	CcSEcCtD
Torasemide—Diarrhoea—Carmustine—brain cancer	0.000327	0.00357	CcSEcCtD
Torasemide—Dizziness—Carmustine—brain cancer	0.000316	0.00345	CcSEcCtD
Torasemide—Pain—Etoposide—brain cancer	0.000316	0.00345	CcSEcCtD
Torasemide—Constipation—Etoposide—brain cancer	0.000316	0.00345	CcSEcCtD
Torasemide—Diarrhoea—Temozolomide—brain cancer	0.000316	0.00345	CcSEcCtD
Torasemide—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000309	0.0174	CbGpPWpGaD
Torasemide—Dizziness—Temozolomide—brain cancer	0.000306	0.00333	CcSEcCtD
Torasemide—Vomiting—Carmustine—brain cancer	0.000304	0.00332	CcSEcCtD
Torasemide—Rash—Carmustine—brain cancer	0.000302	0.00329	CcSEcCtD
Torasemide—Dermatitis—Carmustine—brain cancer	0.000301	0.00328	CcSEcCtD
Torasemide—Headache—Carmustine—brain cancer	0.0003	0.00327	CcSEcCtD
Torasemide—Vomiting—Temozolomide—brain cancer	0.000294	0.0032	CcSEcCtD
Torasemide—Rash—Temozolomide—brain cancer	0.000291	0.00318	CcSEcCtD
Torasemide—Dermatitis—Temozolomide—brain cancer	0.000291	0.00317	CcSEcCtD
Torasemide—Headache—Temozolomide—brain cancer	0.00029	0.00316	CcSEcCtD
Torasemide—Nausea—Carmustine—brain cancer	0.000284	0.0031	CcSEcCtD
Torasemide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000276	0.0155	CbGpPWpGaD
Torasemide—Nausea—Temozolomide—brain cancer	0.000275	0.00299	CcSEcCtD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000267	0.015	CbGpPWpGaD
Torasemide—Asthenia—Etoposide—brain cancer	0.000265	0.00289	CcSEcCtD
Torasemide—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000263	0.0148	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000255	0.0144	CbGpPWpGaD
Torasemide—Diarrhoea—Etoposide—brain cancer	0.000253	0.00276	CcSEcCtD
Torasemide—Dizziness—Etoposide—brain cancer	0.000245	0.00267	CcSEcCtD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000238	0.0134	CbGpPWpGaD
Torasemide—Vomiting—Etoposide—brain cancer	0.000235	0.00256	CcSEcCtD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000235	0.0132	CbGpPWpGaD
Torasemide—Rash—Etoposide—brain cancer	0.000233	0.00254	CcSEcCtD
Torasemide—Dermatitis—Etoposide—brain cancer	0.000233	0.00254	CcSEcCtD
Torasemide—Headache—Etoposide—brain cancer	0.000232	0.00253	CcSEcCtD
Torasemide—Nausea—Etoposide—brain cancer	0.00022	0.0024	CcSEcCtD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000216	0.0122	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000193	0.0109	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000178	0.01	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000118	0.00663	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000115	0.00647	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000113	0.00638	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000109	0.00614	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000103	0.00577	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000101	0.0057	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.83e-05	0.00385	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	6.3e-05	0.00355	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5e-05	0.00281	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.41e-05	0.00248	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.94e-05	0.00222	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.23e-05	0.00182	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP2C9—brain cancer	3.04e-05	0.00171	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.88e-05	0.00162	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.63e-05	0.00148	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—BSG—brain cancer	2.59e-05	0.00146	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—IDH1—brain cancer	2.22e-05	0.00125	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2C9—brain cancer	1.97e-05	0.00111	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.81e-05	0.00102	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ENO2—brain cancer	1.76e-05	0.00099	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP2C9—brain cancer	1.75e-05	0.000988	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—BSG—brain cancer	1.67e-05	0.000941	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—BSG—brain cancer	1.49e-05	0.00084	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—IDH1—brain cancer	1.44e-05	0.000809	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—BSG—brain cancer	1.36e-05	0.000766	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—IDH1—brain cancer	1.28e-05	0.000722	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.17e-05	0.000659	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—IDH1—brain cancer	1.17e-05	0.000658	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ENO2—brain cancer	1.14e-05	0.000639	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.04e-05	0.000588	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ENO2—brain cancer	1.01e-05	0.000571	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.52e-06	0.000536	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ENO2—brain cancer	9.24e-06	0.00052	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CG—brain cancer	8.07e-06	0.000454	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CG—brain cancer	5.21e-06	0.000293	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CG—brain cancer	4.65e-06	0.000262	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CG—brain cancer	4.24e-06	0.000239	CbGpPWpGaD
